| Id |
Subject |
Object |
Predicate |
Lexical cue |
| TextSentencer_T1 |
0-107 |
Sentence |
denotes |
Homozygous hypobetalipoproteinemia: a disease distinct from abetalipoproproteinemia at the molecular level. |
| T1 |
0-107 |
Sentence |
denotes |
Homozygous hypobetalipoproteinemia: a disease distinct from abetalipoproproteinemia at the molecular level. |
| TextSentencer_T2 |
108-251 |
Sentence |
denotes |
apoB DNA, RNA, and protein from two patients with homozygous hypobetalipoproteinemia (HBL) were evaluated and compared with normal individuals. |
| T2 |
108-251 |
Sentence |
denotes |
apoB DNA, RNA, and protein from two patients with homozygous hypobetalipoproteinemia (HBL) were evaluated and compared with normal individuals. |
| TextSentencer_T3 |
252-383 |
Sentence |
denotes |
Southern blot analysis with 10 different cDNA probes revealed a normal gene without major insertions, deletions, or rearrangements. |
| T3 |
252-383 |
Sentence |
denotes |
Southern blot analysis with 10 different cDNA probes revealed a normal gene without major insertions, deletions, or rearrangements. |
| TextSentencer_T4 |
384-536 |
Sentence |
denotes |
Northern and slot blot analyses of total liver mRNA from HBL patients documented a normal size apoB mRNA that was present in greatly reduced quantities. |
| T4 |
384-536 |
Sentence |
denotes |
Northern and slot blot analyses of total liver mRNA from HBL patients documented a normal size apoB mRNA that was present in greatly reduced quantities. |
| TextSentencer_T5 |
537-708 |
Sentence |
denotes |
ApoB protein was detected within HBL hepatocytes utilizing immunohistochemical techniques; however, it was markedly reduced in quantity when compared with control samples. |
| T5 |
537-708 |
Sentence |
denotes |
ApoB protein was detected within HBL hepatocytes utilizing immunohistochemical techniques; however, it was markedly reduced in quantity when compared with control samples. |
| TextSentencer_T6 |
709-785 |
Sentence |
denotes |
No apoB was detectable in the plasma of HBL individuals with an ELISA assay. |
| T6 |
709-785 |
Sentence |
denotes |
No apoB was detectable in the plasma of HBL individuals with an ELISA assay. |
| TextSentencer_T7 |
786-951 |
Sentence |
denotes |
These data are most consistent with a mutation in the coding portion of the apoB gene in HBL patients, leading to an abnormal apoB protein and apoB mRNA instability. |
| T7 |
786-951 |
Sentence |
denotes |
These data are most consistent with a mutation in the coding portion of the apoB gene in HBL patients, leading to an abnormal apoB protein and apoB mRNA instability. |
| TextSentencer_T8 |
952-1153 |
Sentence |
denotes |
These results are distinct from those previously noted in abetalipoproteinemia, which was characterized by an elevated level of hepatic apoB mRNA and accumulation of intracellular hepatic apoB protein. |
| T8 |
952-1153 |
Sentence |
denotes |
These results are distinct from those previously noted in abetalipoproteinemia, which was characterized by an elevated level of hepatic apoB mRNA and accumulation of intracellular hepatic apoB protein. |